Schedule 13G ownership disclosure
AMAG PHARMACEUTICALS INC.
Security class unavailable · CUSIP: 00163U106
Event date: 2017-05-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.8500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-17-005096
- Form type
- SC 13G
- Filer
- AMAG PHARMACEUTICALS, INC.
- CIK
- CIK 792977
- Filed
- May 25, 2017
- Reporting period
- May 23, 2017
- Description
- Schedule 13G beneficial ownership